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I. Executive Summary and Overall Evaluation 
 
The Space Radiation Standing Review Panel (from here on referred to as the SRP) was 
impressed with the strong research program presented by the scientists and staff associated with 
NASA’s Space Radiation Program Element and National Space Biomedical Research Institute 
(NSBRI).  The presentations given on-site and the reports of ongoing research that were 
provided in advance indicated the potential Risk of Acute and Late Central Nervous System 
Effects from Radiation Exposure (CNS) and were extensively discussed by the SRP.  This new 
data leads the SRP to recommend that a higher priority should be placed on research designed to 
identify and understand these risks at the mechanistic level.  To support this effort the SRP feels 
that a shift of emphasis from Acute Radiation Syndromes (ARS) and carcinogenesis to CNS-
related endpoints is justified at this point.  However, these research efforts need to focus on 
mechanisms, should follow pace with advances in the field of CNS in general and should 
consider the specific comments and suggestions made by the SRP as outlined below.  The SRP 
further recommends that the Space Radiation Program Element continue with its efforts to fill 
the vacant positions (Element Scientist, CNS Risk Discipline Lead) as soon as possible.  The 
SRP also strongly recommends that NASA should continue the NASA Space Radiation Summer 
School.  In addition to these broad recommendations, there are specific 
comments/recommendations noted for each risk, described in detail below. 
 
II. Comments regarding the new Gap metrics that have been developed for the 
Risk of Acute and Late Central Nervous System Effects from Radiation 
Exposure (CNS) 
 
 Regarding the CNS risk associated with exposure to space radiation, the SRP thinks that such 
risks may be real based on a summary of all of the data available now.  Thus, the Research 
Rating for CNS should be changed from “Insufficient Data” to “Unacceptable”, if results 
obtained in mice can be confirmed in primates and humans.  In light of this, increased research 
resources should be directed to the CNS studies effective immediately.  Considering that 
research resources are limited, the SRP feels that increased support for the CNS studies could be 
accomplished by rebalancing the ratio of support for the carcinogenesis studies vs. CNS since 
our understanding of the carcinogenesis risks is maturing.  Increased support for CNS research 
should not, however, come at the expense of the support for the degenerative risks, which is also 
at a relatively low level. 
 The evidence presented regarding the effects of low-dose heavy ions on the CNS is compelling.  
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effects, determine the mechanism(s) underlying the observed alterations and to begin 
investigating potential countermeasures.  Based upon this, the SRP has a number of specific 
recommendations regarding these future directions: 
1. First, the initial studies have utilized a wide variety of different animal models (i.e., non-
transgenic mice and rats, Alzheimer’s disease transgenic models and others) and behavioral 
paradigms (mostly hippocampal tasks including novel object recognition, odor recognition, 
etc.).  However, in order to further characterize the effects on the CNS and attempt to relate 
these findings to what might occur in humans traveling in deep space, it will ultimately be 
important to develop a core set of animal models and behavioral paradigms that could be 
effectively utilized across multiple different studies supported by NASA.  This will help 
close the gaps identified and relate to humans as quickly as possible. 
2. For animal models, initial screening and characterization of the effects of low-dose heavy 
ions should continue to be performed in rodents.  Currently, each research group supported 
by NASA utilizes different species, genetic backgrounds and transgenes.  There is a concern 
that each model will likely generate a unique response to low-dose heavy ions and will thus 
make it difficult to consolidate these data into a consensus risk assessment for humans.  
Therefore, the SRP recommends that the Human Research Program (HRP) should develop a 
core set of recommended rodent models, including those that most closely resemble human 
astronauts, especially with regards to genetic diversity that could provide novel insights into 
individual susceptibility (i.e., collaborative cross, outbred stocks).  In addition, the SRP 
recommends that future animal studies begin to examine a wide variety of tissue and body 
fluid biomarkers that can be specifically related to the CNS effects of low-dose heavy ion 
exposure.  Identification of such biomarkers will be critical in efforts to relate these findings 
to humans as quickly as possible.  Following the initial screening and characterization studies 
in rodents, the SRP recommends that the HRP consider additional animal models to extend 
these findings to other species (i.e., non-human primates, micro-pigs).  Finally, astronauts 
have developed brains, and many of the animal models use juveniles with a developing CNS, 
which is an entirely different paradigm.  Therefore, greater consideration should be given to 
the maturity level of CNS models. 
3. For behavioral paradigms, most of the current studies have focused on hippocampal-based 
tasks of learning and memory.  While these studies are certainly important, the SRP 
recommends that the HRP also encourage research into the effects of low-dose heavy ions on 
behavioral paradigms focused on processing speed and retrieval (see bullet #5 below).  
Notably, it will be important to work together with the Behavioral Health and Performance 
Element in generating recommended behavioral measures in rodents that are relevant to 
human astronauts.  Such efforts will assist in relating the findings in animal models to human 
astronauts and developing more reliable estimates of risk. 
4. In addition to animal studies characterizing the effects of low-dose heavy ions on the CNS 
and mechanistic studies focused on identifying the underlying biology, NASA should also 
consider examining the impact of well-characterized countermeasures on CNS functions.  
Notably, these efforts could focus on countermeasures already being instituted (i.e., exercise, 
sleep), or for which there is substantial evidence that the countermeasure could be effective 
and rapidly deployed in humans. 
5. Astronauts are highly trained, extremely smart individuals, so paradigms for acute risk 
should perhaps focus more on the effects of radiation on cerebral white matter and non-
hippocampal based cognitive functions (e.g., reaction time, fatigue, inefficient memory 
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retrieval), and not so much on hippocampal-based cognitive functions such as new learning 
and consolidation, let alone novel object recognition.  As Dr. Mike Robbins (Professor of 
Radiation Biology from Wake Forest University, passed away in November 2012) put it, 
radiation exposure causes chronic oxidative stress and inflammation, increased production of 
reactive oxygen species leading to lipid peroxidation, oxidation of DNA and proteins, 
activation of pro-inflammatory factors, and progressive loss of hippocampal-dependent and 
non-hippocampal dependent cognitive functions.  Therefore, in the short run the crew may 
know what to do but how fast and efficient are they at doing it? 
 Specifically for the CNS risk presentation, there was an absence of gamma-ray/X-ray 
comparison data in the studies highlighted.  The SRP thinks that the HRP should 
encourage investigators to include gamma-ray/X-ray controls in all studies of HZE 
effects.  This is important for two reasons:  1) it allows for relative biological 
effectiveness (RBE) calculations, and 2) assessment of CNS risks from gamma-rays/X-
rays may be critical for assessing risks for the low linear energy transfer LET components 
of space radiation.  Radiation exposures on the International Space Station (ISS) would 
represent one such example. 
 Countermeasures:  Countermeasures against risk do not rely totally on understanding 
mechanisms (although that understanding is important in the long run).   There are a 
number of empirical measures that are known to work, as in exercise (for example, 
physical fitness, hippocampal and other brain region neurogenesis, working off pent-up 
emotions), psychostimulants to the degree that fatigue and neurobehavioral slowing are 
issues, watching a comedy show once in a while and laughing, etc.  And, anti-emetics for 
nausea, and all sorts of effective medications against all sorts of symptoms. 
 Individual susceptibility for CNS:  Individual susceptibility is an issue, and researchers 
are encouraged to focus less on “cognitive” genes (e.g., APOE-4, COMT, BDNF) and 
consider the at-risk alleles of genes that might have an interaction with radiation exposure 
(inflammatory pathway, DNA repair, metabolizing genes).  There is also a genetic dose 
issue – and screening people, as unpleasant as it may look, is not without precedent – 
particularly when the objective is protection, rather than selection. 
 Non-human primates:  Although it is a difficult to get permission to do non-human 
primate studies, the effects being seen in rodents on cognitive function and possible 
degenerative effects from simulated deep space radiation are important enough that 
NASA needs to know if they actually occur in primate brains.  The SRP is not suggesting 
large studies but small “n” studies to verify if the effects both behavioral and biochemical 
actually do occur or are something only seen in the much smaller brains of rodents.  
Essentially this is a proof of principle study that the risk seen in rodents will translate to 
human or at least non-human primates. 
 Cancer Patients undergoing Radiotherapy with Protons and Heavy Ions Represent 
a unique Cohort for Studying acute CNS Effects:  Several studies carried out thus far 
within the Space Radiation Program Element using animal models (mainly mice) suggest 
that acute CNS effects impairing cognitive functions cannot be excluded after exposure to 
low doses of particle radiation.  It is inferred that if effects of similar magnitude, with 
comparable radiation sensitivity, also occur in humans, they will present a serious acute 
risk to long duration space missions, where sizeable doses of radiation may be received 
by the astronauts.  It will be particularly useful to analyze this risk through studies 
directly in humans.  A daily increasing number of patients undergo treatment for brain 
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and head and neck tumors using C-12 and protons.  During treatment of these patients, 
their brains are exposed to particle radiation directly or indirectly, according to a 
treatment plan that hits extremely well defined centers of the brain, while attempting to 
optimally target the tumor.  Doses in the range between a few Gy up to 10 or even 20 Gy 
may be given in the course of such treatments.  These patients represent a unique 
resource for studying the possible acute impairment of cognitive functions following 
irradiation of different centers of the brain.  One can envision the recruitment as 
volunteers (but with a sizeable remuneration to make it attractive) in a prospective study, 
of patients without major impairment in mental faculties as a result of their tumor.  Such 
individuals may be tested continuously, parallel to the course of their fractionated 
radiation therapy for impairment in CNS function.  Several tests are conceivable for this 
purpose (many must actually already exist) including impairment in learning, orientation, 
reflexes, ability to perform calculations etc., and could be carried out minutes, hours, 
weeks or months after the exposure.  Available, highly demanding video games may also 
be used for this purpose.  It is likely that some of these tests will be carried out in 
individuals receiving radiation doses in excess to those normally expected in the space 
environment, albeit in only a portion of their brains.  Several institutions are highly 
vested in this type of cancer treatment including the Heidelberg Ion Therapy Centre 
(HIT) facility in Heidelberg, Germany (Director: Prof. Dr. Jurgen Debues) or the 
National Institute of Radiological Science (NIRS) facility in Chiba, Japan (Director: Prof. 
Dr. Tadashi Kamada) and may have patients for inclusion in such a study.  More centers 
are already operational in Japan and more are due to open in the coming years further 
increasing the cohort of patients to draw from in such studies.  Similar cohorts of patients 
may be used in the future, when treatment improves and thus the number of survivors 
increases, to examine increased risk to Alzheimer’s or Huntington diseases as a result of 
a radiation exposure.  A useful control in all above studies will be selected cohorts of 
brain tumor patients exposed to standard high voltage X-ray radiation therapy. 
 Retrospective Analysis of CNS Impairment in Brain Tumor Patients treated with 
Radiation:  Useful information on CNS risks may also be gained by retrospective 
analysis of recorded responses of patients with brain tumors exposed to all types of 
radiation including protons and C-12.  Records may be analyzed for indications of mental 
deterioration as a result of radiation therapy.  A serious confounding factor in this type of 
study, as well as in the one proposed above, is expected to be the normal mental 
deterioration of the patient as a result of disease progression.  This confounding factor 
needs to be carefully considered and controlled both in the above suggested prospective 
study, and when possible in a retrospective study. 
 The need for mechanistic studies:  While reading the reports of ongoing studies on the 
effects of heavy ions on CNS, it becomes apparent that several of them test highly 
complex endpoints that cannot at present be understood in a mechanistic way.  As many 
of the studies simply test the action of radiation on such endpoints, they remain by 
necessity purely phenomenological.  While a solution to this problem will have to await 
better mechanistic understanding of brain function, an effort should be made to conceive 
studies, which at least attempt to understand the increased efficacy of heavy ions.  In the 
field of carcinogenesis, increased efficacy is explained by increased complexity of the 
damage induced in the DNA.  Why are heavy ions more efficacious when CNS effects 
are investigated?  What are the targets?  Is DNA playing a role?  Is damage to 
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membranes more important in this context?  Work that will at least attempt to delineate 
some of these open questions is certainly highly relevant to the Space Radiation Program 
Element. 
 
i. Is the overall redirection as represented in the CNS gaps, metrics and tasks 
sufficient to properly address the risk? 
 
 The SRP suggests that a higher priority be given to study the systems biology of CNS 
effects at the tissue and whole organ levels, to include both neural and stromal cell 
damage, senescence, and death; damage to the extra-cellular matrix; and whether 
spatially-linked damage (micro-lesions) may define unique biological effects for HZE 
exposure.  [The portfolio already contains studies of molecular/DNA damage in cell 
cultures, as well as the behavioral effects on whole organisms.] 
 With respect to the gap metrics system, it is unclear how the Space Radiation 
Program Element derived the percent numbers that a gap would be closed by if a 
metric were achieved.  How are these percentages calculated?  Are they just estimates 
at this stage? 
 The SRP also thinks that metrics should be action items not questions if the data are 
sufficient to put the risk in the red, yellow or green zone and should only be questions 
in the gray zone, where there are not enough data or understanding to determine if a 
risk exists. 
 The overall approach to setting out metrics for gap closure and delineation in a series 
of “action” items was well received by the SRP.  It will be important as this approach 
is applied to all gaps that the items listed in the metrics and the importance of each 
item is matched in solicitation language and is easily available for review by 
applicants.  Investigators should be encouraged to address the action items in grant 
applications. 
 
III. Comments regarding the Other Space Radiation Program Element 
Risks 
 
 The Risk of Acute Radiation Syndromes Due to Solar Particle Events (SPEs) 
o Much of the work done with ARS is being done by investigators funded by the 
NSBRI.  This division between ARS and other radiation toxicities is artificial and 
does not benefit NASA’s overall interests.  Despite these concerns, however, 
communications between NSBRI and NASA have improved, and there may be some 
benefits of having some aspects of the NASA portfolio handled by NSBRI.  Since 
radiation studies make up a portion of the NSBRI program, further study into the 
general utility of NSBRI to the NASA program would require an analysis of broader 
scope than the SRP can provide. 
o In the Center of Acute Radiation Research (CARR) mini-pig studies they mentioned 
that blood endpoints did not return to normal even after a long period.  It is not clear 
if the mini-pig is inbred or out bred and if this effect on blood cells is a likely result in 
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 The Risk Of Degenerative Tissue Or Other Health Effects From Radiation Exposure 
o With respect to the assumption of threshold for degenerative and some CNS effects, 
recent data on some endpoints is suggestive of non-deterministic effects (that is there 
may not be thresholds for all endpoints).  The SRP suggests keeping an open mind on 
this issue and not expect threshold effects and encourage investigators to look at low 
doses to define whether endpoints are seeing stochastic or deterministic events. 
o There was some discussion by the SRP that NASA looks for or solicits models of 
long-term degenerative risks.  Many of the examples presented to the SRP seemed to 
be acute or short-term models.  NASA might challenge investigators to show how 
these models relate to long-term effects. 
 
 The Risk of Radiation Carcinogenesis 
o Small molecule studies are showing that many of the effects of radiation, for example 
inflammation, can be targeted and that such molecules can be given after exposure 
and still are effective.  In the case of degenerative and CNS effects, it will be useful to 
follow this maturing field of study for suitable molecules to be tested with space 
simulating radiations.  It is not clear yet that any radiation mitigator studies are able to 
address the cancer endpoint. 
 
IV.   Additional Comments 
 
 The SRP strongly encourages NASA to fill the vacant positions for Element Scientist, 
and CNS Discipline Chair as soon as possible to facilitate timely completion of needed 
collaborations and experiments and to enhance the overall work of the Space Radiation 
Program Element as a whole.  An effort should be made to attract individuals with 
expertise covering all facets of the program including, carcinogenesis, non-cancer effects 
and CNS effect. 
 Small “n” studies (such as the twin study) can be very useful and inform larger studies.  
The SRP suggests that an “n” of three would be better (two astronauts, one in space for a 
less amount of time for a while back, which might address repair processes, one twin 
with a longer period in space and more acutely studied, and perhaps a demographically 
similar person with no space exposure, to see what is different).  In addition, regarding 
the twin study and small “n” studies; there was consensus on the SRP that both the twin 
study and other small “n” studies should be related as much as possible to rigorous 
similar larger “n” studies from other sources using the same or similar endpoints. 
 The SRP encourages continued use of powerful recombinant backcross mouse population 
models that better simulate human populations.  One such mouse population model is the 
Collaborative Cross (http://csbio.unc.edu/CCstatus/index.py).  These model populations 
should also be valuable in studies of the CNS. 
 The SRP applauds the continued use of the National Council on Radiation Protection and 
Measurements (NCRP), the International Commission on Radiological Protection 
(ICRP), and the National Academies for occasional reviews of specific space radiation 
research focus areas. 
 The SRP strongly supports continued yearly operation of the NASA Space Radiation 
Summer School at the U.S. Department of Energy's Brookhaven National Laboratory.  
The three-week course has been offered each summer for nine years, and provides a 
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critical pipeline of young experimentalists cognizant in biological effects of HZE particle 
exposure.  The information and the feedback members of the committee received from 
the scientific community are uniformly positive regarding the value and the importance 
of the NASA Space Radiation Summer School.  The NASA Space Radiation Summer 
School helps to attract and train young individuals in the field of radiation and helps thus 
maintain vigorous research activity as required to address the programmatic aims of the 
NASA Space Radiation Program Element.  The SRP therefore feels strongly that the 
NASA Space Radiation Summer School needs to be preserved. 
 Dose and dose rate.  Many of the studies presented to the SRP from ongoing research 
used starting doses of 2 Gy and there seemed to be a lack of focus on doses below 1 Gy, 
which will be more meaningful for most situations in proposed deep space travel.  Some 
endpoints described may not occur at lower doses.  The SRP suggests the Space 
Radiation Program Element challenge investigators to prove endpoints are important at 
lower more relevant doses.  On low dose rate (or fractionation) there are few studies so 
far.  As endpoints are validated investigators should be motivated to move to chronic or 
fractionated exposures to make sure the effects can be seen under more chronic 
conditions. 
 The SRP was not in agreement with the Space Radiation Program Element’s plans to 
only focus on Food and Drug Administration (FDA)-approved drugs for countermeasure 
research.  The SRP thinks additional approaches should be discussed in the context of 
what is appropriate for a deep space traveler.  Current FDA-approved drugs/biologics are 
only aimed at acute effects of radiation.  There are no drugs/biologics approved or even 
in the pipeline that are designed to mitigate the effects of radiation on cancer risk and/or 
degenerative risks.  So it may make sense to begin a process to screen radio-mitigating 
biologics that can be given during or after an exposure for effectiveness against cancer 
and degenerative risks.  The Space Radiation Program Element should also consider 
using the FDA Investigational New Drug (IND) process to evaluate promising biologics 
and not insist on full approval.  Last, the SRP discussed and certainly encourages the 
Space Radiation Program Element (within the constraint of peer reviewed science) to 
look at other ways to mitigate radiation risks such as exercise, shielding, dietary 
intervention, sleep cycles, etc.  It is perhaps time to begin a combined analysis of all 
countermeasures to determine what routes can be safely undertaken during a deep space 
mission and after the deep space travelers return to Earth. 
 Rather than integration, the SRP thinks there should be strong “interaction” or 
collaboration with the other Program Elements within the HRP. 
 The SRP thinks the issue of choosing the shielding to be used and its resulting spectrum 
of radiation spallation products is becoming critical to moving the related radiobiology 
forward. 
 Overall individual radiosensitivity/susceptibility:  Individual radiosensitivity, cancer 
susceptibility etc. should be considered seriously not as basis for selection, but rather 
from the perspective of radiation protection.  Information along these lines should be 
generated to help NASA protect astronauts with increased radiosensitivity or cancer 
susceptibility.  Such predisposition is highly likely for carcinogenesis, but could also be 
present for acute and delayed CNS effects. 
 Limitations of Animal Model Systems:  Diverse animal model systems have been used in 
the past within the NASA programs to study sensitivity to radiation at different end 
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points, intending to anticipate in this way human responses to similar insults.  This 
approach is justified and valid.  With results accumulating from ongoing work it is 
becoming increasingly evident, at times proportionally to the volume of available data, 
that different animal model systems can generate widely divergent radiosensitivity 
results, at least for certain end points.  This development allows two inferences that are 
worth incorporating in future strategies for shaping the program.  First, although the 
unanticipated variation in response confounds the original programmatic aim of the work, 
it should now be regarded by itself as one of its most valuable outcomes – i.e., without 
the work this limitation would not have been identified.  Second, it demonstrates that 
animal model systems need validation for relevance to anticipated human responses 
before utilization in long-term, high-cost studies.  Recognition of this limitation and the 
obvious difficulty in addressing this complication suggests that priority should be given 
to obtaining as much information as feasible directly in humans (see recommendations 
above). 
 Meeting in person:  The SRP feels that meeting in person is more effective than meeting 
through teleconference calls.  The direct interactions and the personal contact, not only 
between the members of the SRP but also with members of the Space Radiation Program 
Element, NSBRI, and other NASA representatives, enables a more intense and fruitful 
exchange of ideas, the clarification of critical issues or of misunderstandings, thus 
expediting and optimizing the overall steering of the program. 
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V. 2013 Space Radiation Standing Review Panel Status Review:  Statement 
of Task for the Risk of Acute and Late Central Nervous System Effects from 
Radiation Exposure, the Risk of Acute Radiation Syndromes Due to Solar 
Particle Events (SPEs), the Risk Of Degenerative Tissue Or Other Health 
Effects From Radiation Exposure, and the Risk of Radiation Carcinogenesis  
 
The 2013 Space Radiation Standing Review Panel (SRP) will participate in a Status Review that 
will occur via a site visit meeting with the Human Research Program (HRP) Chief Scientist, 
Deputy Chief Scientist and members of the Space Radiation Program Element.  The purpose of 
this review is for the SRP to:  
 
1. Receive an update by the HRP Chief Scientist or Deputy Chief Scientist on the status of 
NASA’s current and future exploration plans and the impact these will have on the HRP. 
 
2. Receive an update on any changes within the HRP since the 2012 SRP meeting. 
 
3. Receive an update by the Element or Project Scientist(s) on progress since the 2012 SRP 
meeting. 
 
a. The Space Radiation Element is in the process of redirecting their research 
program for their Acute, Cancer, Central Nervous Central (CNS), and 
Degenerative (Degen) risks.   
b. Gap metrics have been developed for CNS as a test case for new direction.   
i. Is the overall redirection as represented in the CNS gaps, metrics and tasks 
sufficient to properly address the risk? 
c.  Receive an update on Acute, Cancer and Degen risks. 
 
4. Participate in a discussion with the HRP Chief Scientist, Deputy Chief Scientist, and the 
Element regarding possible topics to be addressed at the next SRP meeting 
 
The 2013 Space Radiation SRP will produce a report/comments from this status review 
within 30 days of the 2013 update.  These comments will be submitted to the HRP Chief 
Scientist and copies will be provided to the Space Radiation Program Element and also made 
available to the other HRP Elements.  The 2013 SRP Final Report will be made available on 
the HRR website (http://humanresearchroadmap.nasa.gov/). 
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